GenMont Biotech Incorporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 90.95 million compared to TWD 103.77 million a year ago. Net income was TWD 23.3 million compared to TWD 30.6 million a year ago. Basic earnings per share from continuing operations was TWD 0.27 compared to TWD 0.35 a year ago. Diluted earnings per share from continuing operations was TWD 0.27 compared to TWD 0.35 a year ago. Basic earnings per share was TWD 0.27 compared to TWD 0.35 a year ago. Diluted earnings per share was TWD 0.27 compared to TWD 0.35 a year ago.